Media center

LATEST NEWS

Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency

22 Aug 2019

FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA

Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)

2 Jul 2019

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY

Invokana® (canagliflozin) Significantly Reduced Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in New CREDENCE Analysis

11 Jun 2019

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Mundipharma announces exclusive outsourcing distribution agreement with Egis Pharmaceuticals for Pelmeg▼® in Central and Eastern Europe

13 May 2019

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY

MEDIA RESOURCES

LATEST VIDEOS